Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin

(NASDAQ:KURA), SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced receipt of a $30 million milestone payment under its collaboration agreement with Kyowa Kirin in connection with the dosing of the first […]

Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook

(NYSE:INSP), MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2025. Recent Business Highlights Generated revenue

FibroGen to Report Third Quarter 2025 Financial Results

(NASDAQ:FGEN), SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will announce third quarter 2025 financial results on Monday, November 10 after market close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time with the investment community to further detail the company's corporate and financial performance.

Fluor Corporation Class Action: Levi & Korsinsky Reminds Fluor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 14, 2025 – FLR

(NYSE:FLR), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fluor Corporation (“Fluor Corporation” or the “Company”) (NYSE: FLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fluor Corporation investors who were adversely affected by alleged securities fraud between February

Class Action Filed Against WPP plc (WPP) – December 8, 2025 Deadline to Join – Contact Levi & Korsinsky

(NYSE:WPP), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in WPP plc (“WPP” or the “Company”) (NYSE: WPP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of WPP investors who were adversely affected by alleged securities fraud between February 27, 2025

Investors who lost money on KBR, Inc. (KBR) should contact Levi & Korsinsky about pending Class Action – KBR

(NYSE:KBR), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in KBR, Inc. (“KBR, Inc.” or the “Company”) (NYSE: KBR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KBR, Inc. investors who were adversely affected by alleged securities fraud between May

NIDEC ALERT: Bragar Eagel & Squire, P.C. is Investigating Nidec Corporation on Behalf of Nidec Stockholders and Encourages Investors to Contact the Firm

NIDEC ALERT: Bragar Eagel & Squire, P.C. is Investigating Nidec Corporation on Behalf of Nidec Stockholders and Encourages Investors to Contact the Firm GlobeNewswire November 03, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nidec (NJDCY) To Contact Him Directly To Discuss Their Options If you purchased

ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors Should Contact the Firm to Potentially Recover Losses

ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors Should Contact the Firm to Potentially Recover Losses GlobeNewswire November 03, 2025 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Block & Leviton is investigating Alvotech (NASDAQ: ALVO) for potential securities law violations. Investors who have lost money in their Alvotech investment should contact

Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin

Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin – Milestone triggered by dosing of first patient in the second of two frontline AML Phase 3 clinical trials – GlobeNewswire November 03, 2025 SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a

Gibson Energy Declares Dividend

Gibson Energy Declares Dividend GlobeNewswire November 03, 2025 All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, Nov. 03, 2025 (GLOBE NEWSWIRE) — Gibson Energy Inc. (TSX:GEI) (“Gibson”, or the “Company”) announced today that its Board of Directors has approved a quarterly dividend of $0.43 per common share, payable on January 16,

Scroll to Top